The advancements in cancer treatments through Dr. Scott Rocklage

Dr. Scott Rocklage is a partner at the 5AM Ventures. He is 61 years of age. He inspires many in entrepreneurship and biochemical research industry for his great achievements. He started working at 5AM Ventures in 2003. He is greatly experienced in the healthcare management where he has worked for close to 30 years. Dr. Scott Rocklage is based in Boston. He has experience in strategic leadership in the healthcare and venture capital area among others.

Dr. Scott Rocklage has served in different companies in different positions. Some of the positions he has held include Chairman and a CEO at Cubist Pharmaceuticals, an executive chairman at Miikana and Ilypsa among others. He now serves on Boards of a couple of companies including Pulmatrix and Rennovia. This is a clear indication of his exemplary leadership skills.

Dr. Scott has a Bachelor of Science degree in Chemistry. He studied this at the University of California. He also has a Doctor of Philosophy degree in Chemistry. He achieved this from the Massachusets Institute of Technology. Dr. Scott conducted his research in Richard Schrock’s, the Nobel Prize Winner for 2005, laboratory. Learn more about Orange Coast College: and

Through his continued strategic leadership he has led to the FDA approval of the application of three new drugs namely: Cubicin®, Teslascan®, and Omniscan™. He has also entered 6 patients into clinical drug tests. He is also an inventor and co-inventor in over 30 United States Patents.

5AM Ventures is at its early stages and is focused on the science of life. Dr. Scott Rocklage joined the company as a Venture Partner and grew into a Managing Partner, the position he currently holds in the company. Read more: Scott Rocklage | LinkedIn

His days are comprised of studying life sciences, working with the Company’s management team, preparation and attendance of the Board meetings among other duties. His line of work involves him working with other entrepreneurs in the life science including scientists.

He helps these people bring their ideas into life through creating potential drugs to meet the untapped needs in the medical industry. Dr. Scott appreciates the use of modern ways of detecting and solving or preventing medical related problems. 5AM Ventures, therefore, supports the companies that use modern technologies.

Dr. Rocklage uses a hands-on approach to determine the most lucrative businesses to invest in and expand. He recently acknowledged the progress that has been made towards getting a treatment for cancer which targets specific mutations. In the near future, he hopes that the lives of many can now be prolonged using this cure.